BOARD OF DIRECTORS
Microbix’s board members have extensive experience that is relevant and helpful to the company. Their qualifications include accounting and finance, contracts and law, life sciences and medical care, as well as corporate governance.
The board takes an active role in developing vision and strategy, advising management on key matters and providing oversight on policies and reporting.
CHAIRMAN OF THE BOARD
Mr. Marino has over 30 years of experience in corporate legal roles and executive management functions, with particular emphasis in transaction based activities related to domestic and international corporate development. He also has considerable experience in conflict resolution and litigation management.
Mark A. Cochran, Ph.D.
Dr. Cochran has been serving on the board since 1988. His professional experience spans all levels of the drug discovery and development value chain including operational and executive roles in venture capital, pharmaceutical and biotechnology industries. His previous experience includes Bayer Pharmaceuticals, last serving as Vice President of Business Development, Biotechnology, in Berkeley, California. He is currently Managing Director, Johns Hopkins HealthCare Solutions, an operating division of Johns Hopkins Medicine/ HealthCare.
Mr. Groome is the President and CEO of Microbix. Before joining Microbix, he was CEO of a company listed on the TSX Venture Exchange and EVP of a TSX-listed company – both in life sciences. Prior to his operational roles, he headed the healthcare activities of two national investment dealers. He has more than 25 years of experience as a leader, executive, equity analyst, investment banker, and corporate advisor. He has also been a member of the Life Sciences Advisory Group of Global Affairs Canada, and a director of public and private companies.
Vaughn C. Embro-Pantalony
Mr. Embro-Pantalony has served as a Director of the Company since 2007. He has held several executive positions in life sciences with responsibility for licensing, business development, and strategic planning, including VP Finance & CFO of Novopharm Limited; VP, Information Technology & CIO of Bayer Inc., VP, Finance & Administration of Bayer Healthcare; and General Manager, Nitrogen Products for Terra International (Canada) Ltd. He is a Chartered Director (C. Dir.) and Audit Committee Certified (A.C.C.) through the Directors College, McMaster University.
Dr. Peter M. Blecher
Dr. Peter Blecher has worked as an Emergency Room physician for over 25 years. He is the Medical Director of CPM Centres for Pain Management since 2005, and is a credentialed pain practitioner with both the American and Canadian Academies of Pain Medicine. As well, Dr. Blecher is a co-founder and Chief Medical Officer of Starseed Medicinal, Inc., an ACMPR federally-licensed medical cannabis company.
Mr. Renner, CEO and partner in Zydus Pharmaceuticals, Pennington N.J., has over 25 years experience in the pharmaceutical industry. He has had a successful career leading businesses with many drug approvals in the US.
Anthony J. Giovinazzo
DIRECTOR & CHAIR OF HR, COMP., & GOV. COMMITTEE
Mr. Giovinazzo has over 40 years of life sciences experience and is an internationally-recognized expert in life sciences IP, drug development, and product commercialization. He was previously the CEO of Cynapsus Therapeutics and currently serves as Executive chairman of Sublimity Therapeutics, as a director of Pond Technologies Holdings Inc. (TSXV: POND), and as a director of Titan Medical Inc. (TSX: TMD, NASDAQ: TMDI).